OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adavosertib and beyond: Biomarkers, drug combination and toxicity of WEE1 inhibitors
Chi Zhang, Ke Peng, Qing Liu, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104233-104233
Closed Access | Times Cited: 8
Chi Zhang, Ke Peng, Qing Liu, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104233-104233
Closed Access | Times Cited: 8
Showing 8 citing articles:
Targeting refractory diffuse large B cell lymphoma by CAR-WEE1 T-cells: In vitro evaluation
Hadeer Mohamed Ahmed, Said S. Moselhy, Magda I. Mohamad, et al.
Annals of Hematology (2025)
Open Access
Hadeer Mohamed Ahmed, Said S. Moselhy, Magda I. Mohamad, et al.
Annals of Hematology (2025)
Open Access
Targeting the DNA damage response in cancer
Guffanti Federica, Chiappa Michela, Giovanna Damia
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 4
Guffanti Federica, Chiappa Michela, Giovanna Damia
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 4
High WEE1 expression is independently linked to poor survival in multiple myeloma
Anish K. Simhal, Ross Firestone, Jung Hun Oh, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
Anish K. Simhal, Ross Firestone, Jung Hun Oh, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer
Sanat Kulkarni, Ketankumar Gajjar, Srinivasan Madhusudan
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Sanat Kulkarni, Ketankumar Gajjar, Srinivasan Madhusudan
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Enhancing oncogenic signaling to kill cancer cells
Amir Noeparast, Oleg Timofeev, Martin Pichler
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 475-477
Open Access
Amir Noeparast, Oleg Timofeev, Martin Pichler
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 475-477
Open Access
High WEE1 expression is independently linked to poor survival in multiple myeloma
Anish K. Simhal, Ross Firestone, Jung Hun Oh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Anish K. Simhal, Ross Firestone, Jung Hun Oh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Antibody–drug conjugates in gastric cancer: from molecular landscape to clinical strategies
Jia-Lin Hao, Xinyun Li, Yu‐Tong Liu, et al.
Gastric Cancer (2024) Vol. 27, Iss. 5, pp. 887-906
Closed Access
Jia-Lin Hao, Xinyun Li, Yu‐Tong Liu, et al.
Gastric Cancer (2024) Vol. 27, Iss. 5, pp. 887-906
Closed Access
Novel Indazole Compounds as PKMYT1 Kinase Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 1810-1811
Open Access
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 1810-1811
Open Access
